We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Livedoid Vasculopathy in a Pediatric Patient With Elevated Lipoprotein(a) Levels: Prompt Response to Continuous Low-Molecular-Weight Heparin

Tobias Goerge, MD; Carsten Weishaupt, MD; Dieter Metze, MD; Ulrike Nowak-Göttl, MD; Cord Sunderkötter, MD; Martin Steinhoff, MD, PhD; Stefan W. Schneider, MD
Arch Dermatol. 2010;146(8):918-935. doi:10.1001/archdermatol.2010.177.
Text Size: A A A
Published online


Callen  JP Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol 2006;142 (11) 1481- 1482
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.142.11.1481]]
Hairston  BRDavis  MDPittelkow  MRAhmed  I Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006;142 (11) 1413- 1418
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.142.11.1413]]
Erqou  SKaptoge  SPerry  PL  et al. Emerging Risk Factors Collaboration, Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009;302 (4) 412- 423
PubMed Link to Article[[XSLOpenURL/10.1001/jama.2009.1063]]
Hairston  BRDavis  MDGibson  LEDrage  LA Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 2003;139 (8) 987- 990
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.139.8.987]]
Papi  MDidona  BDe Pita  O  et al.  Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol 1998;134 (4) 447- 452
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.134.4.447]]
Anglés-Cano  Ede la Pena Diaz  ALoyau  S Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci 2001;936261- 275
PubMed Link to Article[[XSLOpenURL/10.1111/(ISSN)1749-6632]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1.

Clinical photographs from the patient. A, Lightning-shaped livedo racemosa with partial necrosis and crusts before treatment. B, Residual postinflammatory hyperpigmentation and atrophic scarring but no ulceration after 4 months of treatment. Therapy was paused at this time.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Documentation of malleolar skin pain on a visual analog scale (VAS) ranging from 0 (no pain) to 10 (extreme pain). Arrows indicate changes in low-molecular-weight heparin therapy, 1 mg/kg/d. Observe the rapid regression of pain after treatment initiation and recurrence of pain after cessation of therapy.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

16 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections